Combination Immunotherapy of B16 Melanoma Using Anti–Cytotoxic T Lymphocyte–Associated Antigen 4 (Ctla-4) and Granulocyte/Macrophage Colony-Stimulating Factor (Gm-Csf)-Producing Vaccines Induces Rejection of Subcutaneous and Metastatic Tumors Accompanied by Autoimmune Depigmentation

We examined the effectiveness of cytotoxic T lymphocyte–associated antigen 4 (CTLA-4) blockade, alone or in combination with a granulocyte/macrophage colony-stimulating factor (GM-CSF)–expressing tumor cell vaccine, on rejection of the highly tumorigenic, poorly immunogenic murine melanoma B16-BL6....

Descripción completa

Detalles Bibliográficos
Autores principales: van Elsas, Andrea, Hurwitz, Arthur A., Allison, James P.
Formato: Texto
Lenguaje:English
Publicado: The Rockefeller University Press 1999
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2195583/
https://www.ncbi.nlm.nih.gov/pubmed/10430624

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2195583/
https://www.ncbi.nlm.nih.gov/pubmed/10430624

Ejemplares similares